Expert Commentary

The One Step test: The better diagnostic approach for gestational diabetes mellitus

OBG Manag. 2019 December;31(12):22-24

PDF Download

References

Kampmann U, Madsen LR, Skajaa GO, et al. Gestational diabetes: a clinical update. World J Diabetes. 2015;6:1065-1072.
HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991-2002.
Meltzer SJ, Snyder J, Penrod JR, et al. Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one-step and two-step methods. BJOG. 2010;117:407-415.
Sevket O, Ates S, Uysal O, et al. To evaluate the prevalence and clinical outcomes using a one-step method versus a two-step method to screen gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2014;27:36-41.
Scifres CM, Abebe KZ, Jones KA, et al. Gestational diabetes diagnostic methods (GD2M) pilot randomized trial. Matern Child Health J. 2015;19:1472-1480.
Farrar D, Duley L, Medley N, et al. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev. 2015;1:CD007122.
American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(suppl 1):S11-S24.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Diabetes and Pregnancy. Can J Diabetes. 2013;37(suppl 1):S168-S183.
NICE guideline. Diabetes in pregnancy: management from preconception to the postnatal period. February 2015. https://www.nice.org.uk/guidance/ng3/. Last updated August 2015. Accessed November 18, 2019.
WHO 1999. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. From http://apps.who.int/iris/bitstream/10665/66040/1/WHO
_NCD_NCS_99.2.pdf. Accessed November 18, 2019.
World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. 2013. http://apps.who.int/iris/bitstream/10665/85975/1/WHO_
NMH_MND_13.2_eng.pdf. Accessed November 18, 2019.
Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(suppl 3):S173-S211.
Berghella V, Caissutti C, Saccone G, et al. The One Step approach for diagnosing gestational diabetes is associated with better perinatal outcomes than using the Two Step approach: evidence of randomized clinical trials. Am J Obstet Gynecol. 2019;220:562-564.
Berghella V, Caissutti C, Saccone G, et al. One-Step approach to identifying gestational diabetes mellitus: association with perinatal outcomes. Obstet Gynecol. 2019;133:383.
American College of Obstetricians and Gynecologists. Committee on Practice Bulletins—Obstetrics. Practice Bulletin No. 180: gestational diabetes mellitus. Obstet Gynecol. 2017;130:e17-e31.
Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768-773.
National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039-1057.
Saccone G, Khalifeh A, Al-Kouatly HB, et al. Screening for gestational diabetes mellitus: one step versus two step approach. A meta-analysis of randomized trials. J Matern Fetal Neonatal Med. 2018:1-9.
Saccone G, Caissutti C, Khalifeh A, et al. One step versus two step approach for gestational diabetes screening: systematic review and meta-analysis of the randomized trials. J Matern Fetal Neonatal Med. 2019;32:1547-1555.
Khalifeh A, Eckler R, Felder L, et al. One-step versus two-step diagnostic testing for gestational diabetes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2018:1-6.
Caissutti C, Saccone G, Khalifeh A, et al. Which criteria should be used for starting pharmacologic therapy for management of gestational diabetes in pregnancy? Evidence from randomized controlled trials. J Matern Fetal Neonatal Med. 2019;32:2905-2914.
Caissutti C, Saccone G, Ciardulli A, et al. Very tight vs. tight control: which should be the criteria for pharmacologic therapy dose adjustment in diabetes in pregnancy? Evidence from randomized controlled trials. Acta Obstet Gynecol Scand. 2018;97:235-247.
Caissutti C, Khalifeh A, Saccone G, et al. Are women positive for the One Step but negative for the Two Step screening tests for gestational diabetes at higher risk for adverse outcomes? Acta Obstet Gynecol Scand. 2018;97:122-134.

References

Kampmann U, Madsen LR, Skajaa GO, et al. Gestational diabetes: a clinical update. World J Diabetes. 2015;6:1065-1072.
HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991-2002.
Meltzer SJ, Snyder J, Penrod JR, et al. Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one-step and two-step methods. BJOG. 2010;117:407-415.
Sevket O, Ates S, Uysal O, et al. To evaluate the prevalence and clinical outcomes using a one-step method versus a two-step method to screen gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2014;27:36-41.
Scifres CM, Abebe KZ, Jones KA, et al. Gestational diabetes diagnostic methods (GD2M) pilot randomized trial. Matern Child Health J. 2015;19:1472-1480.
Farrar D, Duley L, Medley N, et al. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev. 2015;1:CD007122.
American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(suppl 1):S11-S24.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Diabetes and Pregnancy. Can J Diabetes. 2013;37(suppl 1):S168-S183.
NICE guideline. Diabetes in pregnancy: management from preconception to the postnatal period. February 2015. https://www.nice.org.uk/guidance/ng3/. Last updated August 2015. Accessed November 18, 2019.
WHO 1999. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. From http://apps.who.int/iris/bitstream/10665/66040/1/WHO
_NCD_NCS_99.2.pdf. Accessed November 18, 2019.
World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. 2013. http://apps.who.int/iris/bitstream/10665/85975/1/WHO_
NMH_MND_13.2_eng.pdf. Accessed November 18, 2019.
Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(suppl 3):S173-S211.
Berghella V, Caissutti C, Saccone G, et al. The One Step approach for diagnosing gestational diabetes is associated with better perinatal outcomes than using the Two Step approach: evidence of randomized clinical trials. Am J Obstet Gynecol. 2019;220:562-564.
Berghella V, Caissutti C, Saccone G, et al. One-Step approach to identifying gestational diabetes mellitus: association with perinatal outcomes. Obstet Gynecol. 2019;133:383.
American College of Obstetricians and Gynecologists. Committee on Practice Bulletins—Obstetrics. Practice Bulletin No. 180: gestational diabetes mellitus. Obstet Gynecol. 2017;130:e17-e31.
Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768-773.
National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039-1057.
Saccone G, Khalifeh A, Al-Kouatly HB, et al. Screening for gestational diabetes mellitus: one step versus two step approach. A meta-analysis of randomized trials. J Matern Fetal Neonatal Med. 2018:1-9.
Saccone G, Caissutti C, Khalifeh A, et al. One step versus two step approach for gestational diabetes screening: systematic review and meta-analysis of the randomized trials. J Matern Fetal Neonatal Med. 2019;32:1547-1555.
Khalifeh A, Eckler R, Felder L, et al. One-step versus two-step diagnostic testing for gestational diabetes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2018:1-6.
Caissutti C, Saccone G, Khalifeh A, et al. Which criteria should be used for starting pharmacologic therapy for management of gestational diabetes in pregnancy? Evidence from randomized controlled trials. J Matern Fetal Neonatal Med. 2019;32:2905-2914.
Caissutti C, Saccone G, Ciardulli A, et al. Very tight vs. tight control: which should be the criteria for pharmacologic therapy dose adjustment in diabetes in pregnancy? Evidence from randomized controlled trials. Acta Obstet Gynecol Scand. 2018;97:235-247.
Caissutti C, Khalifeh A, Saccone G, et al. Are women positive for the One Step but negative for the Two Step screening tests for gestational diabetes at higher risk for adverse outcomes? Acta Obstet Gynecol Scand. 2018;97:122-134.

The One Step test: The better diagnostic approach for gestational diabetes mellitus

References

US guidelines should be reconsidered

Pages

Recommended Reading